Bronchospasm News and Research

RSS
Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Alexza completes FDA review for AZ-004 NDA

Alexza completes FDA review for AZ-004 NDA

FDA approves Cumberland's Acetadote Injection

FDA approves Cumberland's Acetadote Injection

Dendreon provides U.S. commercialization and European strategy updates for PROVENGE

Dendreon provides U.S. commercialization and European strategy updates for PROVENGE

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Pharmaxis to present ARIDOL Bronchial Challenge Test Kit at 2010 ACAAI

Pharmaxis to present ARIDOL Bronchial Challenge Test Kit at 2010 ACAAI

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Acetadote Injection is now commercially available in Australia

Acetadote Injection is now commercially available in Australia

Pharmaxis receives FDA approval to market ARIDOL Test Kit

Pharmaxis receives FDA approval to market ARIDOL Test Kit

FDA extends review on Acetadote for non-acetaminophen acute liver failure

FDA extends review on Acetadote for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine

Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine

Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis

Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms